Our fifth webinar with Novartis will feature how the Sustainable Development Goals (SDGs) are linked to corporate responsibility materiality assessments.
In recent webinars, we have covered concepts that help us comprehend and manage the impact of Novartis on society and the environment at large as well as our dependencies to these spheres. On December 11, we aim to explore the relevance of the SDGs in the context of corporate materiality.
We are delighted to welcome Robert G. Eccles, Professor of Management Practice at the Harvard Business School and Saïd Business School to speak about his research on this topic. We are looking forward to debate how business can and should contribute to the achievement of the global 2030 agenda.
Rob Cameron, Chief Executive, SustainAbility
Robert G. Eccles, Professor of Management Practice, Harvard Business School & Saïd Business School (Visiting Professor)
Kileken ole-MoiYoi, Head Strategy Global Health & Corporate Responsibility, Novartis
Denise Weger, Senior Manager Strategic Initiatives Global Health & Corporate Responsibility, Novartis
For more information please read our recent reports, Corporate Responsibility Materiality Assessment Results Report 2017 and the Novartis In Society Report 2018.